Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Formulary Balancing Act: Medicare Rules Weigh Access Versus Cost Control

Executive Summary

The Medicare prescription drug benefit implementing regulations would require formularies to contain at least two drugs in every therapeutic class

You may also be interested in...



USP Working Toward Medicare Formulary PBMs Can Use, McClellan Says

U.S. Pharmacopeia will make sure its model Medicare formulary guidelines "work" for prescription drug plan sponsors as it constructs the final version, Centers for Medicare & Medicaid Services Administrator Mark McClellan says

USP Working Toward Medicare Formulary PBMs Can Use, McClellan Says

U.S. Pharmacopeia will make sure its model Medicare formulary guidelines "work" for prescription drug plan sponsors as it constructs the final version, Centers for Medicare & Medicaid Services Administrator Mark McClellan says

Ketek, Allegra Deserve Special Formulary Status – Aventis Consultants

The ketolide drug class should be added to the U.S. Pharmacopeia's model drug classification system as a unique pharmacologic class, Stephen Jenkins, PhD, Carolinas Medical Center said during an Aug. 27 public meeting on the proposed Medicare Rx formulary guidelines

Related Content

Topics

UsernamePublicRestriction

Register

ID036688

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel